Vertex Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors
I'm PortAI, I can summarize articles.
Vertex Pharmaceuticals Inc. (VRTX) shares fell 1.31% to $453.74 on Tuesday, marking the third consecutive day of losses. The stock is now 12.69% below its 52-week high of $519.68. In comparison, AbbVie Inc. (ABBV) decreased by 0.48%, while Arcturus Therapeutics Holdings Inc. (ARCT) saw a slight increase of 0.49%. Overall, the stock underperformed against its competitors amid a declining market, with the S&P 500 and Dow Jones also experiencing losses.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments